Eli Lilly is gearing up to invest over $1 billion in India, dramatically boosting its manufacturing power to keep pace with the skyrocketing demand across the region, Reuters reports
Browsing: Biotech
Jim Cramer shines a spotlight on Novo Nordisk A/S (NVO) as “Canada’s backdoor” in a recent Insider Monkey report, highlighting the pharma giant’s daring strategies and thrilling growth prospects throughout North America
Astellas Pharma has launched an exciting new program offering dedicated lab space exclusively for Japanese biotech start-ups, designed to ignite their growth and fast-track their path to the global stage. This bold initiative is set to unleash innovation and boost international competitiveness like never before
4Moving Biotech has secured a €7.6 million grant from France 2030 to advance its innovative, first-in-class disease-modifying drug for osteoarthritis. This funding will support the company’s efforts to transform treatment options for this widespread condition.